Published in Eye (Lond) on April 12, 2013
Intrasurgical plasmin enzyme in diabetic macular edema. Am J Ophthalmol (2004) 2.10
Vitreomacular traction syndrome: a comparison of treatment with intravitreal plasmin enzyme vs spontaneous vitreous separation without treatment. Eye (Lond) (2012) 1.60
Intravitreal injection of microplasmin for treatment of vitreomacular adhesion: results of a prospective, randomized, sham-controlled phase II trial (the MIVI-IIT trial). Retina (2010) 1.59
Vitreomacular traction syndrome: the role of intravitreal plasmin injection is still not clear. Eye (Lond) (2013) 0.92
Vitamin E, atherosclerosis and thrombosis. Thromb Haemost (2001) 1.98
Vitreomacular traction syndrome: a comparison of treatment with intravitreal plasmin enzyme vs spontaneous vitreous separation without treatment. Eye (Lond) (2012) 1.60
Platelet activation by superoxide anion and hydroxyl radicals intrinsically generated by platelets that had undergone anoxia and then reoxygenated. Circulation (1997) 1.54
IPF2alpha-I: an index of lipid peroxidation in humans. Proc Natl Acad Sci U S A (1998) 1.43
Macular thickness measured by optical coherence tomography (OCT) in diabetic patients. Eur J Ophthalmol (2003) 1.38
Localization of distinct F2-isoprostanes in human atherosclerotic lesions. J Clin Invest (1997) 1.38
Nonvisible subthreshold micropulse diode laser (810 nm) treatment of central serous chorioretinopathy. A pilot study. Eur J Ophthalmol (2008) 1.29
Diabetic retinopathyA clinical update. Diabetologia (2002) 1.26
Orbital and ocular manifestations of acute childhood leukemia: clinical and statistical analysis of 180 patients. Eur J Ophthalmol (2008) 1.20
Selective photocoagulation in Coats' disease: ten-year follow-up. Eur J Ophthalmol (2003) 1.16
Ranibizumab for subfoveal choroidal neovascularization in Bietti crystalline retinopathy. Eye (Lond) (2010) 1.10
Bilateral juxtafoveolar telangiectasis in monozygotic twins. Am J Ophthalmol (2000) 1.06
Unusual presentations of type 2 idiopathic macular telangiectasia. Ophthalmologica (2013) 1.06
Bullous pemphigoid: an unusual and insidious presentation of breast cancer. Clin Oncol (R Coll Radiol) (2003) 1.05
Cystoid macular oedema after extracapsular cataract extraction and intraocular lens implantation in diabetic patients without retinopathy. Br J Ophthalmol (1993) 1.03
High-resolution spectral domain optical coherence tomography features in adult onset foveomacular vitelliform dystrophy. Br J Ophthalmol (2010) 1.00
How to select patient candidates for antioxidant treatment? Circulation (2002) 1.00
Down's syndrome is associated with increased 8,12-iso-iPF2alpha-VI levels: evidence for enhanced lipid peroxidation in vivo. Ann Neurol (2000) 1.00
Updating on intraoperative light-induced retinal injury. Int Ophthalmol (1995) 0.97
Superoxide anion and hydroxyl radical release by collagen-induced platelet aggregation--role of arachidonic acid metabolism. Thromb Haemost (2000) 0.95
Iron-dependent human platelet activation and hydroxyl radical formation: involvement of protein kinase C. Circulation (1999) 0.94
Evolving European guidance on the medical management of neovascular age related macular degeneration. Br J Ophthalmol (2006) 0.93
[Fluoroiridographic aspects of iridoschisis]. J Fr Ophtalmol (1988) 0.93
Iris fluorescein angiography in clinical practice. Surv Ophthalmol (1997) 0.92
Normal exophthalmometric values in children. Am J Ophthalmol (1989) 0.92
Optical coherence tomography in idiopathic epiretinal macular membrane surgery. Eur J Ophthalmol (1999) 0.91
Ranibizumab for retinal angiomatous proliferation in age-related macular degeneration. Eye (Lond) (2010) 0.90
Prevalence of retinopathy in diabetic subjects from out-patient clinics in Lombardy (Italy), and associated risk factors. A multicentre epidemiologic study. Diabetes Res Clin Pract (1989) 0.88
OCT images and surgery of juvenile Macular retinoschisis. Eur J Ophthalmol (1997) 0.88
Spectral-domain OCT in anti-VEGF treatment of myopic choroidal neovascularization. Eye (Lond) (2012) 0.88
Effect of aldose reductase inhibition on glutathione redox status in erythrocytes of diabetic patients. Metabolism (1994) 0.86
Theoretical bases of non-ophthalmoscopically visible endpoint photocoagulation. Semin Ophthalmol (2001) 0.86
Ultrasound biomicroscopy following the intraocular use of silicone oil. Int Ophthalmol (1996) 0.86
Apolipoproteins A-I, A-II and B in chronic active hepatitis and in liver cirrhotic patients. Clin Chim Acta (1984) 0.85
Enhanced lipid peroxidation in hepatic cirrhosis. J Investig Med (1998) 0.84
Hydrogen peroxide triggers activation of human platelets selectively exposed to nonaggregating concentrations of arachidonic acid and collagen. J Lab Clin Med (1992) 0.84
Inhibition by picotamide of thromboxane production in vitro and ex vivo. Eur J Clin Pharmacol (1988) 0.83
Influence of hydroxyl radical scavengers on platelet function. Haemostasis (1988) 0.82
Florid diabetic retinopathy (FDR): a long-term follow-up study. Graefes Arch Clin Exp Ophthalmol (2001) 0.82
Peribulbar anesthesia with either 0.75% ropivacaine or a 2% lidocaine and 0.5% bupivacaine mixture for vitreoretinal surgery: a double-blinded study. Anesth Analg (1999) 0.82
Subthreshold laser treatment for retinal arterial macroaneurysm. Br J Ophthalmol (2010) 0.81
Endophotocoagulation through perfluorodecalin in rabbit eyes. Int Ophthalmol (1994) 0.81
Polymorphonuclear leukocyte-derived O2-reactive species activate primed platelets in human whole blood. Am J Physiol (1993) 0.81
Anticardiolipin antibodies and prostacyclin synthesis. Thromb Haemost (1987) 0.81
[Choroidal metastasis from clinically regressed prostate adenocarcinoma: imaging of a rare case]. J Fr Ophtalmol (2008) 0.80
Ongoing prothrombotic state in patients with antiphospholipid antibodies: a role for increased lipid peroxidation. Blood (1999) 0.80
Intravitreal bevacizumab for choroidal neovascularisation in serpiginous choroiditis. Br J Ophthalmol (2014) 0.79
Multiple bilateral choroidal metastatic tumor from bronchial carcinoid: case report. Retina (1998) 0.79
Vitamin E supplementation. Lancet (2001) 0.79
Retinal photocoagulation for proliferative sickle cell retinopathy: a prospective clinical trial with new sea fan classification. Eur J Ophthalmol (2008) 0.79
Central retinal vein and branch artery occlusion associated with inherited plasminogen deficiency and high lipoprotein(a) levels: a case report. Thromb Res (1995) 0.79
Optical Coherence Tomography Angiography of Diabetic Retinopathy. Dev Ophthalmol (2016) 0.78
Succeeding onset of hepatic, splenic, and renal infarction in polyarteritis nodosa. Am J Gastroenterol (2000) 0.78
Superoxide anion scavenging property of dipyridamole. Thromb Haemost (1989) 0.78
Influence of successful pancreaticorenal transplantation on diabetic retinopathy. Transplant Proc (1994) 0.78
Vitamin E reduces monocyte tissue factor expression in cirrhotic patients. Blood (1999) 0.78
Dexamethasone intravitreal implant: an effective adjunctive treatment for recalcitrant noninfectious uveitis. Ophthalmologica (2012) 0.78
Single-sweep analysis using an autoregressive with exogenous input (ARX) model. Doc Ophthalmol (1994) 0.78
Hydrogen peroxide as trigger of platelet aggregation. Haemostasis (1991) 0.78
Proliferative retinopathy and toxemia of pregnancy. Ann Ophthalmol (1987) 0.78
Oxysterols and redox signaling in the pathogenesis of non-alcoholic fatty liver disease. Free Radic Res (2013) 0.77
En face optical coherence tomography visualization of post-traumatic photoreceptor disruption. J Fr Ophtalmol (2013) 0.77
Recurrent central retinal vein occlusion in a young thrombophilic patient with factor V Leiden mutation. Eur J Ophthalmol (2002) 0.77
Laser treatment of iris vascular tufts. Ophthalmologica (1993) 0.77
Perception of, and anxiety levels induced by, laser treatment in patients with sight-threatening diabetic retinopathy. A multicentre study. Diabet Med (2006) 0.77
Normal activities of protein C, protein S and antithrombin III in young patients with retinal vein occlusion. Haematologica (1991) 0.77
Initial clinical experience using a diode red laser (670 nm) in the treatment of retinal disease. Eye (Lond) (2005) 0.77
Familial primary pulmonary hypertension and associated ocular findings. Retina (2001) 0.77
[Efficacy of intravitreal injections of ranibizumab compared to visudyne phototherapy in myopic choroidal neovascularization associated with high myopia]. J Fr Ophtalmol (2011) 0.77
Optical coherence tomography of subfoveal choroidal neovascularization treated with transpupillary thermotherapy. Semin Ophthalmol (2001) 0.77
Uptake of oxidized LDL by human atherosclerotic plaque. Circulation (1997) 0.76
New semiconductor laser for vitreoretinal surgery. Lasers Surg Med (1996) 0.76
Iron, platelet function, and coronary heart disease: a possible link? Circulation (1993) 0.76
Congenital aphakia in Peters' anomaly syndrome. A case report. Acta Ophthalmol Scand (1997) 0.76
Quality of vision: A consensus building initiative for a new ophthalmologic concept. Eur J Ophthalmol (2006) 0.76
Influence of silicone oil on iris microangiopathy in diabetic vitrectomized eyes. Ophthalmology (1993) 0.76
Congenital hypertrophy of retinal pigment epithelium (CHRPE) as a marker for familial adenomatous polyposis (FAP). Eur J Cancer Prev (1993) 0.75
Increased thromboxane metabolites excretion in liver cirrhosis. Thromb Haemost (1998) 0.75
Does wavelength matter when photocoagulating eyes with macular degeneration or diabetic retinopathy? Arch Ophthalmol (1994) 0.75
Clinical trials with vitamin E in cardiovascular disease: are they meaningful? Thromb Haemost (2001) 0.75
Diabetes and visual loss. Ophthalmology (1999) 0.75
Reply to Matonti et al. Eye (Lond) (2013) 0.75
Inhibition of cyclooxygenase-independent platelet aggregation by low vitamin E concentration. Atherosclerosis (1990) 0.75
Antioxidants and ischaemic heart disease. Lancet (1997) 0.75
Indocyanine green angiography features of Malattia leventinese. Br J Ophthalmol (2006) 0.75
Antioxidant treatment decreases the titer of circulating anticardiolipin antibodies: comment on the article by Sambo et al. Arthritis Rheum (2002) 0.75
Effect of ramipril and vitamin E on atherosclerosis. Circulation (2002) 0.75
Selective photocoagulation in Coats disease: ten-year follow-up. Eur J Ophthalmol (2017) 0.75
[Spontaneous rupture of a drusenoid pigment epithelium detachment]. J Fr Ophtalmol (2013) 0.75